Related Experiment Video
Updated: Nov 11, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Atheroembolic kidney disease: The under-recognized silent killer
Gabriel Ștefan1,2, Adrian Zugravu1,2, Simona Stancu1,2
1"Dr. Carol Davila" Teaching Hospital of Nephrology Bucharest Romania.
Atheroembolic kidney disease diagnosis relies on kidney biopsy. However, suspect this condition with acute kidney injury, skin issues, and a recent trigger.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Dermatology
Background:
- Atheroembolic kidney disease (AEKD) is a serious condition caused by cholesterol crystal emboli lodging in small arteries.
- Diagnosis is often delayed due to nonspecific symptoms and the invasive nature of definitive diagnostic methods.
Purpose of the Study:
- To highlight clinical indicators that suggest AEKD in the absence of immediate biopsy confirmation.
- To emphasize the importance of recognizing the characteristic triad of symptoms.
Main Methods:
- Review of clinical presentations of patients with confirmed AEKD.
- Analysis of the correlation between precipitating events, renal failure, and skin manifestations.
Main Results:
- Kidney biopsy confirming cholesterol crystal emboli is the gold standard for AEKD diagnosis.
- A clinical triad of acute to subacute renal failure, skin findings, and a recent precipitating event strongly suggests AEKD.
Conclusions:
- Early clinical suspicion for AEKD is crucial, even before definitive biopsy results.
- Recognizing the triad of symptoms can expedite diagnosis and management, potentially improving patient outcomes.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Peripheral Artery Disease I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations

